(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -13.28%484M | -29.90%2.91B | -34.02%1.95B | -32.97%1.36B | -47.36%558.12M | -8.33%4.15B | -11.56%2.95B | -6.28%2.03B | 6.90%1.06B | 14.66%4.53B |
Operating income | -13.28%484M | -29.90%2.91B | -34.02%1.95B | -32.97%1.36B | -47.36%558.12M | -8.33%4.15B | -11.56%2.95B | -6.28%2.03B | 6.90%1.06B | 14.66%4.53B |
Operating expenses | 11.65%-429.16M | 32.74%-2.4B | 35.75%-1.65B | 34.67%-1.16B | 48.05%-485.75M | 10.01%-3.57B | 13.13%-2.56B | 6.50%-1.78B | -8.12%-935.07M | -17.89%-3.96B |
Gross profit | -24.21%54.85M | -12.72%514.31M | -22.57%299.46M | -20.85%197.92M | -42.23%72.37M | 3.31%589.29M | 0.43%386.73M | -4.68%250.05M | -1.45%125.27M | -3.65%570.4M |
Selling expenses | 1.29%-10.74M | -6.63%-40.94M | -10.87%-35.9M | -16.00%-22.27M | -8.77%-10.88M | 8.21%-38.39M | 8.78%-32.38M | 10.45%-19.2M | 7.29%-10.01M | -29.53%-41.83M |
Administrative expenses | -4.34%-61.42M | 8.02%-263.67M | -5.60%-184.74M | -5.80%-122.81M | 6.96%-58.87M | -4.85%-286.65M | 7.19%-174.95M | 2.25%-116.08M | 0.50%-63.27M | -6.07%-273.38M |
Research and development expenses | -10.14%-56.01M | -0.07%-211.19M | 13.16%-146.24M | 15.06%-97.09M | 27.48%-50.85M | 0.94%-211.04M | -10.34%-168.41M | -11.12%-114.3M | -17.89%-70.12M | -3.51%-213.05M |
Profit from asset sales | --8.52K | 81.36%468.74K | -167.73%-153.01K | -117.25%-20.7K | ---- | 135.79%258.45K | 132.56%225.92K | 118.41%120.05K | 865.31%123.73K | -1,321.04%-722.18K |
Revaluation surplus | 241.72%965.05K | -203.54%-1.62M | 19.31%-2.26M | -74.35%-2.59M | 54.16%-680.94K | 77.37%1.57M | -620.59%-2.8M | -222.45%-1.48M | -594.61%-1.49M | -0.22%884.82K |
-Changes in the fair value of other assets | 241.72%965.05K | -203.54%-1.62M | 19.31%-2.26M | -74.35%-2.59M | 54.16%-680.94K | 77.37%1.57M | -620.59%-2.8M | -222.45%-1.48M | -594.61%-1.49M | -0.22%884.82K |
Impairment and provision | -10.68%1.76M | -582.76%-244.49M | 125.38%3.14M | 61.04%-3.79M | 148.22%1.97M | -37.43%-35.81M | -6,785.77%-12.35M | -1,619.16%-9.73M | 9.36%-4.08M | 12.38%-26.06M |
-Other impairment is provision | -10.68%1.76M | -582.76%-244.49M | 125.38%3.14M | 61.04%-3.79M | 148.22%1.97M | -37.43%-35.81M | -6,785.77%-12.35M | -1,619.16%-9.73M | 9.36%-4.08M | 12.38%-26.06M |
Special items of operating profit | 29.04%43.02M | -27.47%82.78M | 34.95%89.15M | 2.87%56.7M | 50.02%33.34M | 37.39%114.13M | 47.10%66.06M | 76.40%55.12M | 34.58%22.22M | -10.50%83.07M |
Operating profit | -69.06%-32.08M | -278.17%-190.14M | -90.17%4.54M | -115.31%-5.2M | -184.37%-18.98M | 37.05%106.72M | 18.28%46.25M | -16.20%33.98M | -919.98%-6.67M | -42.03%77.87M |
Financing cost | -2.27%3.43M | 260.95%11.88M | 229.60%9.55M | 660.33%5.25M | -6.60%3.51M | -131.88%-7.38M | -144.26%-7.37M | -107.73%-936.53K | -22.35%3.76M | 306.95%23.16M |
Special items of earning before tax | -51.35%259.7K | 233.35%4.51M | -51.74%401.49K | 95.91%1.62M | 613.62%533.81K | -70.97%1.35M | 2.89%831.98K | 8.21%827.73K | -64.32%74.8K | -61.05%4.66M |
Earning before tax | -90.17%-28.39M | -272.56%-173.75M | -63.49%14.5M | -95.08%1.67M | -426.56%-14.93M | -4.73%100.69M | -29.79%39.71M | -36.61%33.87M | -164.40%-2.83M | -30.46%105.68M |
Tax | -14.02%-6.59M | -2.95%-20.53M | -24.16%-14.12M | 11.57%-7.6M | 17.02%-5.78M | 21.95%-19.94M | 51.30%-11.37M | 42.23%-8.6M | 13.88%-6.97M | 25.27%-25.55M |
After-tax profit from continuing operations | -68.90%-34.98M | -340.60%-194.27M | -98.66%379.95K | -123.50%-5.94M | -111.23%-20.71M | 0.76%80.75M | -14.68%28.34M | -34.44%25.27M | -165.61%-9.8M | -31.96%80.13M |
Earning after tax | -68.90%-34.98M | -340.60%-194.27M | -98.66%379.95K | -123.50%-5.94M | -111.23%-20.71M | 0.76%80.75M | -14.68%28.34M | -34.44%25.27M | -165.61%-9.8M | -31.96%80.13M |
Minority profit | 13.02%10.94M | 6.65%43.59M | 32.82%32.09M | 61.32%21.4M | 35.43%9.68M | 6.98%40.87M | -19.13%24.16M | -34.53%13.27M | -24.42%7.15M | -5.58%38.2M |
Profit attributable to shareholders | -51.10%-45.92M | -696.55%-237.86M | -859.44%-31.71M | -327.83%-27.34M | -79.27%-30.39M | -4.90%39.87M | 25.23%4.18M | -34.33%12M | -28.92%-16.95M | -45.77%41.93M |
Basic earnings per share | -66.67%-0.05 | -697.02%-0.2603 | -854.35%-0.0347 | -328.24%-0.0299 | -61.29%-0.03 | -5.01%0.0436 | 27.78%0.0046 | -34.50%0.0131 | -29.17%-0.0186 | -45.74%0.0459 |
Diluted earnings per share | -66.67%-0.05 | -697.02%-0.2603 | -854.35%-0.0347 | -328.24%-0.0299 | -61.29%-0.03 | -5.01%0.0436 | 27.78%0.0046 | -34.50%0.0131 | -29.17%-0.0186 | -45.74%0.0459 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data